Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation

BACKGROUND: Post-transplant cyclophosphamide (PT-Cy) has become a standard of care in haploidentical hematopoietic stem cell transplantation (HSCT) to reduce the risk of graft-versus-host disease. However, data on cardiac events associated with PT-Cy are scarce. OBJECTIVES: This study sought to asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Duléry, Rémy, Mohty, Razan, Labopin, Myriam, Sestili, Simona, Malard, Florent, Brissot, Eolia, Battipaglia, Giorgia, Médiavilla, Clémence, Banet, Anne, Van de Wyngaert, Zoé, Paviglianiti, Annalisa, Belhocine, Ramdane, Isnard, Françoise, Lapusan, Simona, Adaeva, Rosa, Vekhoff, Anne, Ledraa, Tounes, Legrand, Ollivier, Cohen, Ariel, Bonnin, Agnès, Ederhy, Stéphane, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352028/
https://www.ncbi.nlm.nih.gov/pubmed/34396331
http://dx.doi.org/10.1016/j.jaccao.2021.02.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352028/
https://www.ncbi.nlm.nih.gov/pubmed/34396331
http://dx.doi.org/10.1016/j.jaccao.2021.02.011

Ejemplares similares